Table 3 in Assessment of FDA-approved drugs against StrongyloideS rAtti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

Table 3 Activity of levamisole, morantel, and prasterone in the S.ratti model TreatmentDose (mg/kg)No. of rats cured a/investigatedMean adult worm burden (SD)Total adult worm burden reduction (%)Control 1No treatment0/4148 (13.0)–Control 2No treatment0/4221.25 (81.5)–Control 3No treatment0/4121.3 (15.4)–Levamisole100 14/40 (0)10010 24/40 (0)1001 34/468 (18.5)43.9Morantel100 13/30 (0)10010 20/466 (8.6)45.2Prasterone100 10/4137 (39)7.6 Superscripts refer to the respective control batch used in the experiment